Insider Selling: Intuitive Surgical, Inc. (ISRG) COO Sells $2,418,264.02 in Stock
Intuitive Surgical, Inc. (NASDAQ:ISRG) COO Salvatore Brogna sold 6,082 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $397.61, for a total value of $2,418,264.02. Following the completion of the sale, the chief operating officer now directly owns 3,096 shares of the company’s stock, valued at $1,231,000.56. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) opened at $379.04 on Thursday. The company has a market capitalization of $41,452.09, a P/E ratio of 48.96, a price-to-earnings-growth ratio of 5.14 and a beta of 0.48. Intuitive Surgical, Inc. has a one year low of $203.57 and a one year high of $405.05.
Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.78. The business had revenue of $806.10 million during the quarter, compared to the consensus estimate of $753.25 million. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The company’s revenue for the quarter was up 18.0% on a year-over-year basis. During the same period in the prior year, the business posted $2.06 EPS. analysts predict that Intuitive Surgical, Inc. will post 7.85 EPS for the current year.
ISRG has been the subject of a number of research analyst reports. Vetr cut Intuitive Surgical from a “buy” rating to a “hold” rating and set a $111.83 target price for the company. in a research report on Wednesday, August 16th. BidaskClub raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Royal Bank Of Canada reissued a “hold” rating and issued a $333.33 target price on shares of Intuitive Surgical in a research report on Friday, September 1st. Morgan Stanley reissued an “overweight” rating on shares of Intuitive Surgical in a research report on Tuesday, September 5th. Finally, Wedbush reaffirmed an “outperform” rating and set a $353.33 price objective on shares of Intuitive Surgical in a research note on Monday, September 25th. Five investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Intuitive Surgical currently has an average rating of “Buy” and an average target price of $155.78.
TRADEMARK VIOLATION WARNING: “Insider Selling: Intuitive Surgical, Inc. (ISRG) COO Sells $2,418,264.02 in Stock” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/12/07/insider-selling-intuitive-surgical-inc-isrg-coo-sells-2418264-02-in-stock.html.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.